DE3382621D1 - Zwischenprodukte fuer die herstellung von cephemverbindungen, verfahren zu ihrer herstellung und ihre anwendung. - Google Patents

Zwischenprodukte fuer die herstellung von cephemverbindungen, verfahren zu ihrer herstellung und ihre anwendung.

Info

Publication number
DE3382621D1
DE3382621D1 DE8888102767T DE3382621T DE3382621D1 DE 3382621 D1 DE3382621 D1 DE 3382621D1 DE 8888102767 T DE8888102767 T DE 8888102767T DE 3382621 T DE3382621 T DE 3382621T DE 3382621 D1 DE3382621 D1 DE 3382621D1
Authority
DE
Germany
Prior art keywords
production
intermediate products
cephemic
compounds
cephemic compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8888102767T
Other languages
English (en)
Other versions
DE3382621T2 (de
Inventor
Tsutomu Teraji
Kazuo Sakane
Jiro Goto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB838305799A external-priority patent/GB8305799D0/en
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE3382621D1 publication Critical patent/DE3382621D1/de
Publication of DE3382621T2 publication Critical patent/DE3382621T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/08—1,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65613—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system (X = CH2, O, S, NH) optionally with an additional double bond and/or substituents, e.g. cephalosporins and analogs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
DE8888102767T 1982-07-19 1983-07-15 Zwischenprodukte fuer die herstellung von cephemverbindungen, verfahren zu ihrer herstellung und ihre anwendung. Expired - Fee Related DE3382621T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8220833 1982-07-19
GB838305799A GB8305799D0 (en) 1983-03-02 1983-03-02 Cephem compounds

Publications (2)

Publication Number Publication Date
DE3382621D1 true DE3382621D1 (de) 1992-10-15
DE3382621T2 DE3382621T2 (de) 1993-02-18

Family

ID=26283377

Family Applications (2)

Application Number Title Priority Date Filing Date
DE8383106933T Expired DE3380627D1 (en) 1982-07-19 1983-07-15 Cephem compounds, process and intermediates for their preparation and pharmaceutical compositions containing them
DE8888102767T Expired - Fee Related DE3382621T2 (de) 1982-07-19 1983-07-15 Zwischenprodukte fuer die herstellung von cephemverbindungen, verfahren zu ihrer herstellung und ihre anwendung.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE8383106933T Expired DE3380627D1 (en) 1982-07-19 1983-07-15 Cephem compounds, process and intermediates for their preparation and pharmaceutical compositions containing them

Country Status (4)

Country Link
US (3) US4563449A (de)
EP (2) EP0099553B1 (de)
JP (2) JPH037292A (de)
DE (2) DE3380627D1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL74822A (en) * 1984-04-17 1989-06-30 Daiichi Seiyaku Co Cephalosporin derivatives and salts thereof and their preparation
CA1293719C (en) * 1986-09-22 1991-12-31 Takao Takaya Cephem compounds and processes for preparation thereof
DE3722539A1 (de) * 1987-07-08 1989-01-19 Reichenecker Hans Storopack Geschaeumter formkoerper
IE61679B1 (en) * 1987-08-10 1994-11-16 Fujisawa Pharmaceutical Co Water-soluble antibiotic composition and water-soluble salts of new cephem compounds
US5958905A (en) 1996-03-26 1999-09-28 Texas Biotechnology Corporation Phosphoramidates, phosphinic amides and related compounds and the use thereof to modulate the activity of endothelin
KR100361828B1 (ko) * 1997-04-16 2005-08-12 주식회사 엘지생명과학 반응성 유기산 유도체로 부터 세포탁심을 제조하는방법
KR100361829B1 (ko) * 1997-04-16 2005-08-17 주식회사 엘지생명과학 반응성 유기산 유도체로 부터 세프트리악손을 제조하는 방법
TW473479B (en) * 1997-12-19 2002-01-21 Takeda Chemical Industries Ltd Phosphonocephem derivatives, their production and use
US20130065874A1 (en) 2011-09-09 2013-03-14 Cubist Pharmaceuticals, Inc. Methods for treating intrapulmonary infections
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
US20140274997A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Cephalosporin pharmaceutical compositions
CA2906151A1 (en) 2013-03-15 2014-09-18 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
WO2015035376A2 (en) 2013-09-09 2015-03-12 Calixa Therapeutics, Inc. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US8906898B1 (en) 2013-09-27 2014-12-09 Calixa Therapeutics, Inc. Solid forms of ceftolozane

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE541421A (de) * 1954-10-26 1900-01-01
FR1210435A (fr) * 1958-09-26 1960-03-08 Cfmc Procédé de synthèse de la phosphocréatine
NL129633C (de) * 1965-03-05
FR1518199A (fr) * 1966-04-07 1968-03-22 Glaxo Lab Ltd Procédé de préparation d'antibiotiques du type de la céphalosporine
JPS5035079B1 (de) * 1970-10-17 1975-11-13
GB1391437A (en) * 1971-04-07 1975-04-23 Glaxo Lab Ltd Preparation of antibiotic compounds
US4268509A (en) * 1978-07-10 1981-05-19 Fujisawa Pharmaceutical Co., Ltd. New cephem compounds and processes for preparation thereof
AU536842B2 (en) * 1978-12-29 1984-05-24 Fujisawa Pharmaceutical Co., Ltd. Cephalosporin antibiotics
US4443444A (en) * 1980-08-11 1984-04-17 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds

Also Published As

Publication number Publication date
JPH0751591B2 (ja) 1995-06-05
JPH0448796B2 (de) 1992-08-07
EP0099553A2 (de) 1984-02-01
US4563449A (en) 1986-01-07
EP0300121A3 (en) 1990-09-26
DE3380627D1 (en) 1989-11-02
EP0099553B1 (de) 1989-09-27
US4772682A (en) 1988-09-20
EP0300121A2 (de) 1989-01-25
JPH037292A (ja) 1991-01-14
JPH037296A (ja) 1991-01-14
DE3382621T2 (de) 1993-02-18
EP0300121B1 (de) 1992-09-09
US4654422A (en) 1987-03-31
EP0099553A3 (en) 1985-06-19

Similar Documents

Publication Publication Date Title
ATE22806T1 (de) Fibrinogenzubereitung, verfahren zu ihrer herstellung und ihre verwendung.
DE3671627D1 (de) Tertiaere hydroxyalkylxanthine, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung.
DE3575724D1 (de) Quinolizinon-verbindungen, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
DE3576500D1 (de) Carbostyrilverbindungen, diese enthaltende zubereitungen und verfahren zu ihrer herstellung.
DE3485628D1 (de) Kupferartiger katalysator und verfahren zu dessen herstellung.
DE3483957D1 (de) Komplexe, verfahren zu ihrer herstellung und dieselben enthaltende formulierungen.
DE3382621D1 (de) Zwischenprodukte fuer die herstellung von cephemverbindungen, verfahren zu ihrer herstellung und ihre anwendung.
ATE32459T1 (de) Substituierte phenylsulfonyloxybenzimidazolcarbaminate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
ATE40388T1 (de) Vernetzte polymerisate, verfahren zu ihrer herstellung und ihre anwendung.
DE3481120D1 (de) 3,6-disubstituierte-1,8-naphthalimide, verfahren zu ihrer herstellung und ihre verwendung.
DE3677812D1 (de) Polyhydroxypolyether, verfahren zu ihrer herstellung und ihre verwendung.
DE3482258D1 (de) 2,2-difluorpropionsaeurederivate und verfahren zu ihrer herstellung.
DE3381408D1 (de) Zwischenverbindungen fuer die herstellung von ceftazidin und verfahren zu ihrer herstellung.
ATE13053T1 (de) Neue oximaether, verfahren zu ihrer herstellung, mittel die die neuen oximaether enthalten und ihre verwendung.
LU78814A1 (de) Arzneimittel zur bekaempfung von ulcera,oximether und verfahren zu ihrer herstellung
DE3880287D1 (de) Chlortrifluoraethylen-telomere und verfahren zu ihrer herstellung.
ATE15125T1 (de) Ameisenkoeder, verfahren zu deren herstellung und deren verwendung.
DE3484023D1 (de) Azolylmethylcycloalkane, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
AT368527B (de) Katalytische titankomponente und verfahren zu ihrer herstellung
DE68903918D1 (de) Pyrazolverbindungen, verfahren zu deren herstellung, deren anwendung und zwischenprodukte fuer deren herstellung.
DE3583928D1 (de) Cephalosporinzwischenprodukte, verfahren zu ihrer herstellung und ihre verwendung.
DE3768416D1 (de) Iminooxazolidine, verfahren zu ihrer herstellung und ihre verwendung.
PT78585B (de) 5-(4-chlor-3-sulfamoylbenzoyl)-2,3-dihydro-2-benzofurancarbonsaeuren und verfahren zu ihrer herstellung
ATE16007T1 (de) Insektizide, mitizide und nematozide oximphosphatverbindungen und verfahren zu ihrer herstellung.
DE3677259D1 (de) Chinazolinonverbindungen und verfahren zu ihrer herstellung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee